This document provides information on left ventricular aneurysms including:
- A timeline of important discoveries and advances in LV aneurysm research and treatment from 1757 to 1958.
- Definitions, gross pathology, microscopic pathology, location, and natural history of LV aneurysms.
- Clinical features and diagnostic criteria for LV aneurysms.
- Surgical techniques for repairing LV aneurysms including plication, linear closure, patch closure, and endoventricular circular patch repair.
This document discusses primary cardiac tumors, including their presentation, diagnosis, and types. It covers the following key points:
- The majority (75%) of primary cardiac tumors are benign neoplasms. Myxomas are the most common benign tumor, usually originating in the left atrium.
- Clinical presentation varies depending on tumor location and can include embolic phenomena, cardiac manifestations like obstruction, or symptoms of metastatic disease. Echocardiography is the primary diagnostic tool.
- Other common benign primary tumors include papillary fibroelastomas (found on heart valves) and lipomas. Rhabdomyomas are most often seen in children with tuberous sclerosis and can cause arrhythmias
Mitral regurgitation is caused by abnormalities of the mitral valve leaflets, chordae tendineae, or annulus that prevent complete coaptation of the leaflets during systole. The main causes include degenerative diseases like mitral valve prolapse or rheumatic heart disease. Severe mitral regurgitation can lead to left atrial and ventricular dilation and dysfunction over time if left untreated. Echocardiography is the main imaging modality used to assess severity based on regurgitant jet area and velocity. Surgery is recommended for symptomatic patients or asymptomatic patients with severe regurgitation and abnormal ventricular size or function. Mitral valve repair is preferred over replacement when possible due to better long-
This document discusses surgical options for treating heart failure. It begins by providing background on heart failure, including definitions, incidence rates, mortality rates, clinical types, and causes. It then discusses various surgical interventions for acute and chronic heart failure, such as CABG, valve surgery, ventricular reconstruction procedures like the Dor procedure, restraint devices like the Acorn and Myosplint, ventricular assist devices, total artificial hearts, and heart transplantation. The risks, benefits, indications, and outcomes of these different surgical treatments are summarized.
Data is based on ESC & ACC guidelines 2017
Assessment of aortic stenosis severity
Step by step management algorithm
Management in special populations
Case-based questions
MCQs
preop TEE assessment of atrial septal defect is very important for making decision for device closure, properly assessed adequate rims of ASD will reduce risk of device embolization to almost nil.
The document discusses endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms. It presents a case of a 62-year-old male undergoing EVAR for a 5.5cm AAA. EVAR involves deploying a graft via catheter to exclude the aneurysm from blood flow. Complications can include endoleaks, where blood leaks outside the graft but within the aneurysm sac. The main types of endoleaks are type I (inadequate seal at graft ends), type II (collaterals inside the sac), and type III (graft component disruption). EVAR has advantages over open repair like less invasiveness but risks like increased reintervention rates.
Transcatheter closure of sinus venosus atrial septal defectgsquaresolution
This document describes a case of a 35-year-old patient with a sinus venosus atrial septal defect (SVASD) and partial anomalous pulmonary venous connection (PAPVC) of the right upper pulmonary vein. The doctors developed a technique to close this defect using a covered stent placed in the right superior vena cava (RSVC). This separated the common wall of the RSVC and pulmonary vein, allowing the pulmonary vein to drain normally into the left atrium. Imaging after the procedure confirmed the defect was closed and pulmonary vein drainage was corrected without complications at 6-month follow-up, demonstrating the safety and feasibility of this novel transcatheter technique.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise boosts blood flow, releases endorphins, and promotes changes in the brain which help enhance one's emotional well-being and mental clarity.
This document discusses primary cardiac tumors, including their presentation, diagnosis, and types. It covers the following key points:
- The majority (75%) of primary cardiac tumors are benign neoplasms. Myxomas are the most common benign tumor, usually originating in the left atrium.
- Clinical presentation varies depending on tumor location and can include embolic phenomena, cardiac manifestations like obstruction, or symptoms of metastatic disease. Echocardiography is the primary diagnostic tool.
- Other common benign primary tumors include papillary fibroelastomas (found on heart valves) and lipomas. Rhabdomyomas are most often seen in children with tuberous sclerosis and can cause arrhythmias
Mitral regurgitation is caused by abnormalities of the mitral valve leaflets, chordae tendineae, or annulus that prevent complete coaptation of the leaflets during systole. The main causes include degenerative diseases like mitral valve prolapse or rheumatic heart disease. Severe mitral regurgitation can lead to left atrial and ventricular dilation and dysfunction over time if left untreated. Echocardiography is the main imaging modality used to assess severity based on regurgitant jet area and velocity. Surgery is recommended for symptomatic patients or asymptomatic patients with severe regurgitation and abnormal ventricular size or function. Mitral valve repair is preferred over replacement when possible due to better long-
This document discusses surgical options for treating heart failure. It begins by providing background on heart failure, including definitions, incidence rates, mortality rates, clinical types, and causes. It then discusses various surgical interventions for acute and chronic heart failure, such as CABG, valve surgery, ventricular reconstruction procedures like the Dor procedure, restraint devices like the Acorn and Myosplint, ventricular assist devices, total artificial hearts, and heart transplantation. The risks, benefits, indications, and outcomes of these different surgical treatments are summarized.
Data is based on ESC & ACC guidelines 2017
Assessment of aortic stenosis severity
Step by step management algorithm
Management in special populations
Case-based questions
MCQs
preop TEE assessment of atrial septal defect is very important for making decision for device closure, properly assessed adequate rims of ASD will reduce risk of device embolization to almost nil.
The document discusses endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms. It presents a case of a 62-year-old male undergoing EVAR for a 5.5cm AAA. EVAR involves deploying a graft via catheter to exclude the aneurysm from blood flow. Complications can include endoleaks, where blood leaks outside the graft but within the aneurysm sac. The main types of endoleaks are type I (inadequate seal at graft ends), type II (collaterals inside the sac), and type III (graft component disruption). EVAR has advantages over open repair like less invasiveness but risks like increased reintervention rates.
Transcatheter closure of sinus venosus atrial septal defectgsquaresolution
This document describes a case of a 35-year-old patient with a sinus venosus atrial septal defect (SVASD) and partial anomalous pulmonary venous connection (PAPVC) of the right upper pulmonary vein. The doctors developed a technique to close this defect using a covered stent placed in the right superior vena cava (RSVC). This separated the common wall of the RSVC and pulmonary vein, allowing the pulmonary vein to drain normally into the left atrium. Imaging after the procedure confirmed the defect was closed and pulmonary vein drainage was corrected without complications at 6-month follow-up, demonstrating the safety and feasibility of this novel transcatheter technique.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise boosts blood flow, releases endorphins, and promotes changes in the brain which help enhance one's emotional well-being and mental clarity.
Post Myocardial infarction vsd repair by infarct exclusion techniqueJyotindra Singh
This case study examines outcomes of 26 patients who underwent surgical repair of a post-myocardial infarction ventricular septal defect (PMIVSD) over a 15-year period. 20 patients underwent defect closure with concomitant coronary artery bypass grafting (CABG), while 6 had defect closure alone. In-hospital mortality was 30.9%, with higher mortality seen in those with cardiogenic shock, posterior defects, and surgery over 3 weeks after infarction. 15 of the 20 patients who had CABG survived, compared to 3 of the 6 who had defect closure alone. Residual shunts occurred in 5 patients but did not require reoperation. Predictors of poor prognosis included cardiogenic shock, timing of surgery, and total
This document discusses the echocardiographic features used to evaluate Ebstein's anomaly of the tricuspid valve. It describes how to assess the displacement and morphology of the tricuspid valve leaflets, degree of tethering, and dilation of the cardiac chambers. Cut-off values are provided to define abnormalities. The document also reviews how to evaluate tricuspid regurgitation and the anatomy of the tricuspid valve annulus, chordae, and right ventricle outflow tract. Assessment of left ventricular function is also mentioned. Evaluation of Ebstein's anomaly by 2D, M-Mode, Doppler and 3D echocardiography is covered. Scoring systems for evaluating severity and prognosis are
This document provides an overview of aortic stenosis, including its epidemiology, anatomy, causes, pathophysiology, and clinical presentation. Some key points:
- Aortic stenosis is narrowing of the aortic valve that obstructs blood flow from the left ventricle. It most commonly results from calcification of the aortic valve.
- The rate of progression from early valve changes to severe stenosis is typically 1.8-1.9% per year in those over 75, 3.4% have severe stenosis.
- As stenosis progresses, the left ventricle undergoes hypertrophic remodeling to maintain cardiac output, but this impairs diastolic function over time.
- Stages of
1) Pulmonary hypertension (PH) is defined as elevated pulmonary artery pressure, while pulmonary arterial hypertension (PAH) is a subtype caused by constriction and remodeling of small pulmonary arteries.
2) PAH is a progressive disease that involves proliferation of cells in the pulmonary arteries leading to increased pulmonary vascular resistance and right heart failure if left untreated.
3) The document reviews classification of PH, diagnostic testing and evaluation algorithms, goals of treatment, and approved therapies for PAH.
The document provides an overview of right ventricular assessment using echocardiography. It discusses normal RV anatomy, segmental nomenclature, and coronary supply. Key metrics for evaluating RV size, wall thickness, function, and pressures are outlined. Normal values and technical aspects of measuring RV dimensions, area/fractional area change, tricuspid annular plane systolic excursion, myocardial velocity, and diastolic function are summarized. Hemodynamic assessment of pulmonary pressures is also reviewed.
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,Dr.Hasan Mahmud
Transcatheter aortic valve implantation (TAVI) has been developed as an alternative to surgical aortic valve replacement for high-risk patients. TAVI involves threading a collapsible valve through blood vessels and implanting it to replace the diseased valve. Over 30,000 high-risk patients with severe aortic stenosis have undergone TAVI, based on evidence from studies showing it is safer than surgery for this group. TAVI indications may expand as longer-term data on outcomes becomes available and the procedure requires a multidisciplinary team approach and dedicated training.
1) Prosthetic heart valve thrombosis can occur with both mechanical and biological valves and is influenced by surface factors, hemodynamic factors, and hypercoagulability.
2) Clinical presentation may include heart failure symptoms or embolic events, and imaging with TEE is the standard for evaluation.
3) Treatment depends on severity of symptoms and includes anticoagulation, fibrinolytic therapy, or emergency surgery for severe cases.
Restrictive cardiomyopathy is characterized by stiff ventricles that do not fill properly, though systolic function is usually preserved initially. It can be caused by infiltrative diseases, fibrosis, or other processes that restrict ventricular filling. On echocardiogram, restrictive cardiomyopathy shows impaired ventricular filling and enlarged atria, while cardiac catheterization reveals elevated diastolic pressures and a distinctive "square root sign" pressure tracing. Treatment focuses on managing symptoms and underlying causes if identifiable, though prognosis is often poor without transplantation.
This document discusses peripheral pulmonary artery stenosis, including its description, associated conditions, classification, clinical features, diagnosis using imaging modalities like echocardiography and angiography, and treatment options like balloon angioplasty. Peripheral pulmonary artery stenosis can involve the main pulmonary artery or its branches and is present in 2-3% of congenital heart disease cases. Diagnosis relies on cardiac catheterization and angiography to determine severity and anatomy. Balloon angioplasty is an option for treating moderate or severe stenosis when surgery is difficult.
This document summarizes the history and classification of sinus of Valsalva aneurysm (SOVA). Some key points:
- SOVA was first described in 1839 and the first successful repair was in 1956 using cardiopulmonary bypass.
- SOVAs can be congenital or acquired due to various connective tissue/inflammatory disorders.
- The majority originate from the right coronary cusp (77%) and most commonly rupture into the right ventricle (67.9%).
- The classic Sakakibara classification categorizes SOVAs arising from the right coronary cusp into three types based on location of rupture/protrusion. A modified classification exists for non-cor
This document discusses ECG patterns in congenital heart disease. It begins by outlining the significance of ECG in diagnosing congenital heart defects. It then provides an overview of normal ECG changes in children and how they evolve over time as hemodynamics change. Next, it describes how ECG can help identify situs and ventricular position. It then discusses the characteristic ECG patterns seen in common acyanotic defects like atrial septal defects and ventricular septal defects. It also covers cyanotic defects like transposition of the great arteries. The document provides detailed information on ECG features, associated conditions, complications and evolution over time for many different congenital heart defects.
This document discusses the use of echocardiography to evaluate truncus arteriosus, a rare congenital heart defect where a single arterial trunk arises from the heart and gives rise to the pulmonary and systemic circulations. It describes the four types of truncus arteriosus based on the anatomy of the pulmonary arteries. Key echocardiography views and measurements needed to characterize the defect and associated anomalies are provided. The document also briefly discusses surgical repair and additional imaging that may be used.
Arrhythmogenic right ventricular dysplasiaDomina Petric
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited heart muscle disease characterized by structural abnormalities and fatty replacement of the right ventricle muscle leading to ventricular arrhythmias. It is an important cause of sudden cardiac death in young adults. The disease results from genetic mutations that cause programmed cell death and fibrosis of the right ventricle muscle. Diagnosis is based on ECG findings like inverted T-waves in the right ventricle leads and epsilon waves, along with imaging showing right ventricle structural changes. Treatment involves medications like beta-blockers and implantable defibrillators to prevent arrhythmias.
Percutaneous Balloon Mitral Valvuloplasty (PBMV) is a procedure to dilated the mitral valve in the setting of rheumatic mitral valve stenosis. A catheter is inserted into the femoral vein, advanced to the right atrium and across the interatrial septum. Then the mitral valve is crossed with a balloon and it is inflated to relieve the fusion of the mitral valve commissures effectively acting to increase the mitral valve area and reduce the degree of mitral stenosis. Mitral regurgitation is a potential complication and thus PBMV is contraindicated if moderate or severe regurgitation is present. The Wilkins score examines mitral valve morphology and is determined via echocardiography to assess the likelihood of using PBMV based on certain echocardiographic criteria.
Cardiac catheteriztion, Oximetery study in a patient with VSDPRAVEEN GUPTA
In this ppt i am going to discuss how to do cardiac catheterisation study, oximetry study and how to analyse its data in a patient with VSD who came to our hospital
Pulmonary atresia with intact ventricular septum (PAIVS) is a congenital heart defect where the pulmonary valve is blocked, preventing blood flow from the right ventricle to the lungs. It occurs in 1-3% of congenital heart diseases. Surgical interventions for PAIVS have improved, with 5-year survival rates now around 80%. Treatment depends on factors like the size of the tricuspid valve and whether the coronary arteries depend on blood flow from the right ventricle. Options include biventricular repair, univentricular repair, or transplantation.
This document discusses techniques for aortic valve repair surgery. It notes that valve preserving root replacement and aortic valve repair for isolated aortic insufficiency are being used more frequently. However, a limitation is the lack of a common framework for assessing the valve to guide repair approaches. The goal of repair is to restore normal leaflet geometry and mobility. Techniques discussed include remodeling, reimplantation, subcommissural annuloplasty, and triangular resection. Outcomes are generally good, especially for secondary insufficiency and tricuspid valves, but less so for isolated prolapse of one leaflet. Associated procedures and reproducibility of techniques need improvement. Echocardiography plays an important role in assessment and repair
Echocardiography is the main tool for evaluating prosthetic heart valves. Transthoracic echocardiography (TTE) is generally used to assess normal valve function and identify dysfunction like stenosis or regurgitation. Transesophageal echocardiography (TEE) provides better imaging of valve structure and is helpful for evaluating regurgitation and complications like endocarditis. Echocardiograms establish a baseline after valve implantation and monitor for issues like pannus, thrombus, infection or degeneration over time. TTE and TEE are complementary, with TEE used when TTE is inadequate or clinical suspicion remains after a TTE.
This document discusses congenital coronary artery anomalies. It begins by describing the normal anatomy of coronary arteries and veins. It then defines what constitutes a normal versus abnormal coronary variation. The document categorizes coronary anomalies into four groups: those unassociated with congenital heart disease, those associated with congenital heart disease, acquired anomalies associated with congenital heart disease, and anomalies of the coronary venous circulation. It provides examples of specific anomalies that fall into each category and discusses their clinical significance. Particular emphasis is placed on anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA).
Aortic stenosis is a narrowing of the aortic valve that obstructs blood flow from the left ventricle to the aorta. It can be caused by rheumatic heart disease or congenital issues. As the stenosis progresses, it increases left ventricular pressure and causes compensatory hypertrophy. Symptoms include dyspnea, dizziness, angina, and syncope. On examination, one may hear a crescendo-decrescendo murmur and feel a weak pulse. Echocardiography can measure valve area and gradients to diagnose and classify severity. Treatment options include medical management for symptoms or valve replacement surgery or TAVR for severe cases.
Definition of LVA Centerline analysis of RWMA on LV angio in 30º RAO shows hypocontractile segments moving more than 2 standard deviations out of normal range.
The document describes a study of 27 patients in Iraq who underwent surgical treatment for left ventricular aneurysms between 2001-2011. Left ventricular aneurysms are complications that can arise after a myocardial infarction. The patients were mostly middle-aged males and had multiple blocked coronary arteries. Surgical techniques used to repair the aneurysms included linear repair and the Dor procedure. Post-operative complications were common, with the highest rate being bleeding. The overall hospital mortality rate for the surgeries was 18.5%.
Post Myocardial infarction vsd repair by infarct exclusion techniqueJyotindra Singh
This case study examines outcomes of 26 patients who underwent surgical repair of a post-myocardial infarction ventricular septal defect (PMIVSD) over a 15-year period. 20 patients underwent defect closure with concomitant coronary artery bypass grafting (CABG), while 6 had defect closure alone. In-hospital mortality was 30.9%, with higher mortality seen in those with cardiogenic shock, posterior defects, and surgery over 3 weeks after infarction. 15 of the 20 patients who had CABG survived, compared to 3 of the 6 who had defect closure alone. Residual shunts occurred in 5 patients but did not require reoperation. Predictors of poor prognosis included cardiogenic shock, timing of surgery, and total
This document discusses the echocardiographic features used to evaluate Ebstein's anomaly of the tricuspid valve. It describes how to assess the displacement and morphology of the tricuspid valve leaflets, degree of tethering, and dilation of the cardiac chambers. Cut-off values are provided to define abnormalities. The document also reviews how to evaluate tricuspid regurgitation and the anatomy of the tricuspid valve annulus, chordae, and right ventricle outflow tract. Assessment of left ventricular function is also mentioned. Evaluation of Ebstein's anomaly by 2D, M-Mode, Doppler and 3D echocardiography is covered. Scoring systems for evaluating severity and prognosis are
This document provides an overview of aortic stenosis, including its epidemiology, anatomy, causes, pathophysiology, and clinical presentation. Some key points:
- Aortic stenosis is narrowing of the aortic valve that obstructs blood flow from the left ventricle. It most commonly results from calcification of the aortic valve.
- The rate of progression from early valve changes to severe stenosis is typically 1.8-1.9% per year in those over 75, 3.4% have severe stenosis.
- As stenosis progresses, the left ventricle undergoes hypertrophic remodeling to maintain cardiac output, but this impairs diastolic function over time.
- Stages of
1) Pulmonary hypertension (PH) is defined as elevated pulmonary artery pressure, while pulmonary arterial hypertension (PAH) is a subtype caused by constriction and remodeling of small pulmonary arteries.
2) PAH is a progressive disease that involves proliferation of cells in the pulmonary arteries leading to increased pulmonary vascular resistance and right heart failure if left untreated.
3) The document reviews classification of PH, diagnostic testing and evaluation algorithms, goals of treatment, and approved therapies for PAH.
The document provides an overview of right ventricular assessment using echocardiography. It discusses normal RV anatomy, segmental nomenclature, and coronary supply. Key metrics for evaluating RV size, wall thickness, function, and pressures are outlined. Normal values and technical aspects of measuring RV dimensions, area/fractional area change, tricuspid annular plane systolic excursion, myocardial velocity, and diastolic function are summarized. Hemodynamic assessment of pulmonary pressures is also reviewed.
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,Dr.Hasan Mahmud
Transcatheter aortic valve implantation (TAVI) has been developed as an alternative to surgical aortic valve replacement for high-risk patients. TAVI involves threading a collapsible valve through blood vessels and implanting it to replace the diseased valve. Over 30,000 high-risk patients with severe aortic stenosis have undergone TAVI, based on evidence from studies showing it is safer than surgery for this group. TAVI indications may expand as longer-term data on outcomes becomes available and the procedure requires a multidisciplinary team approach and dedicated training.
1) Prosthetic heart valve thrombosis can occur with both mechanical and biological valves and is influenced by surface factors, hemodynamic factors, and hypercoagulability.
2) Clinical presentation may include heart failure symptoms or embolic events, and imaging with TEE is the standard for evaluation.
3) Treatment depends on severity of symptoms and includes anticoagulation, fibrinolytic therapy, or emergency surgery for severe cases.
Restrictive cardiomyopathy is characterized by stiff ventricles that do not fill properly, though systolic function is usually preserved initially. It can be caused by infiltrative diseases, fibrosis, or other processes that restrict ventricular filling. On echocardiogram, restrictive cardiomyopathy shows impaired ventricular filling and enlarged atria, while cardiac catheterization reveals elevated diastolic pressures and a distinctive "square root sign" pressure tracing. Treatment focuses on managing symptoms and underlying causes if identifiable, though prognosis is often poor without transplantation.
This document discusses peripheral pulmonary artery stenosis, including its description, associated conditions, classification, clinical features, diagnosis using imaging modalities like echocardiography and angiography, and treatment options like balloon angioplasty. Peripheral pulmonary artery stenosis can involve the main pulmonary artery or its branches and is present in 2-3% of congenital heart disease cases. Diagnosis relies on cardiac catheterization and angiography to determine severity and anatomy. Balloon angioplasty is an option for treating moderate or severe stenosis when surgery is difficult.
This document summarizes the history and classification of sinus of Valsalva aneurysm (SOVA). Some key points:
- SOVA was first described in 1839 and the first successful repair was in 1956 using cardiopulmonary bypass.
- SOVAs can be congenital or acquired due to various connective tissue/inflammatory disorders.
- The majority originate from the right coronary cusp (77%) and most commonly rupture into the right ventricle (67.9%).
- The classic Sakakibara classification categorizes SOVAs arising from the right coronary cusp into three types based on location of rupture/protrusion. A modified classification exists for non-cor
This document discusses ECG patterns in congenital heart disease. It begins by outlining the significance of ECG in diagnosing congenital heart defects. It then provides an overview of normal ECG changes in children and how they evolve over time as hemodynamics change. Next, it describes how ECG can help identify situs and ventricular position. It then discusses the characteristic ECG patterns seen in common acyanotic defects like atrial septal defects and ventricular septal defects. It also covers cyanotic defects like transposition of the great arteries. The document provides detailed information on ECG features, associated conditions, complications and evolution over time for many different congenital heart defects.
This document discusses the use of echocardiography to evaluate truncus arteriosus, a rare congenital heart defect where a single arterial trunk arises from the heart and gives rise to the pulmonary and systemic circulations. It describes the four types of truncus arteriosus based on the anatomy of the pulmonary arteries. Key echocardiography views and measurements needed to characterize the defect and associated anomalies are provided. The document also briefly discusses surgical repair and additional imaging that may be used.
Arrhythmogenic right ventricular dysplasiaDomina Petric
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited heart muscle disease characterized by structural abnormalities and fatty replacement of the right ventricle muscle leading to ventricular arrhythmias. It is an important cause of sudden cardiac death in young adults. The disease results from genetic mutations that cause programmed cell death and fibrosis of the right ventricle muscle. Diagnosis is based on ECG findings like inverted T-waves in the right ventricle leads and epsilon waves, along with imaging showing right ventricle structural changes. Treatment involves medications like beta-blockers and implantable defibrillators to prevent arrhythmias.
Percutaneous Balloon Mitral Valvuloplasty (PBMV) is a procedure to dilated the mitral valve in the setting of rheumatic mitral valve stenosis. A catheter is inserted into the femoral vein, advanced to the right atrium and across the interatrial septum. Then the mitral valve is crossed with a balloon and it is inflated to relieve the fusion of the mitral valve commissures effectively acting to increase the mitral valve area and reduce the degree of mitral stenosis. Mitral regurgitation is a potential complication and thus PBMV is contraindicated if moderate or severe regurgitation is present. The Wilkins score examines mitral valve morphology and is determined via echocardiography to assess the likelihood of using PBMV based on certain echocardiographic criteria.
Cardiac catheteriztion, Oximetery study in a patient with VSDPRAVEEN GUPTA
In this ppt i am going to discuss how to do cardiac catheterisation study, oximetry study and how to analyse its data in a patient with VSD who came to our hospital
Pulmonary atresia with intact ventricular septum (PAIVS) is a congenital heart defect where the pulmonary valve is blocked, preventing blood flow from the right ventricle to the lungs. It occurs in 1-3% of congenital heart diseases. Surgical interventions for PAIVS have improved, with 5-year survival rates now around 80%. Treatment depends on factors like the size of the tricuspid valve and whether the coronary arteries depend on blood flow from the right ventricle. Options include biventricular repair, univentricular repair, or transplantation.
This document discusses techniques for aortic valve repair surgery. It notes that valve preserving root replacement and aortic valve repair for isolated aortic insufficiency are being used more frequently. However, a limitation is the lack of a common framework for assessing the valve to guide repair approaches. The goal of repair is to restore normal leaflet geometry and mobility. Techniques discussed include remodeling, reimplantation, subcommissural annuloplasty, and triangular resection. Outcomes are generally good, especially for secondary insufficiency and tricuspid valves, but less so for isolated prolapse of one leaflet. Associated procedures and reproducibility of techniques need improvement. Echocardiography plays an important role in assessment and repair
Echocardiography is the main tool for evaluating prosthetic heart valves. Transthoracic echocardiography (TTE) is generally used to assess normal valve function and identify dysfunction like stenosis or regurgitation. Transesophageal echocardiography (TEE) provides better imaging of valve structure and is helpful for evaluating regurgitation and complications like endocarditis. Echocardiograms establish a baseline after valve implantation and monitor for issues like pannus, thrombus, infection or degeneration over time. TTE and TEE are complementary, with TEE used when TTE is inadequate or clinical suspicion remains after a TTE.
This document discusses congenital coronary artery anomalies. It begins by describing the normal anatomy of coronary arteries and veins. It then defines what constitutes a normal versus abnormal coronary variation. The document categorizes coronary anomalies into four groups: those unassociated with congenital heart disease, those associated with congenital heart disease, acquired anomalies associated with congenital heart disease, and anomalies of the coronary venous circulation. It provides examples of specific anomalies that fall into each category and discusses their clinical significance. Particular emphasis is placed on anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA).
Aortic stenosis is a narrowing of the aortic valve that obstructs blood flow from the left ventricle to the aorta. It can be caused by rheumatic heart disease or congenital issues. As the stenosis progresses, it increases left ventricular pressure and causes compensatory hypertrophy. Symptoms include dyspnea, dizziness, angina, and syncope. On examination, one may hear a crescendo-decrescendo murmur and feel a weak pulse. Echocardiography can measure valve area and gradients to diagnose and classify severity. Treatment options include medical management for symptoms or valve replacement surgery or TAVR for severe cases.
Definition of LVA Centerline analysis of RWMA on LV angio in 30º RAO shows hypocontractile segments moving more than 2 standard deviations out of normal range.
The document describes a study of 27 patients in Iraq who underwent surgical treatment for left ventricular aneurysms between 2001-2011. Left ventricular aneurysms are complications that can arise after a myocardial infarction. The patients were mostly middle-aged males and had multiple blocked coronary arteries. Surgical techniques used to repair the aneurysms included linear repair and the Dor procedure. Post-operative complications were common, with the highest rate being bleeding. The overall hospital mortality rate for the surgeries was 18.5%.
A true aneurysm of the left ventricle has a large neck relative to its depth on 2D echocardiography, and the surrounding normal myocardium thins as it becomes the aneurysm wall. A pseudo aneurysm has a smaller neck compared to its depth, the surrounding myocardium does not thin and remains normal thickness, and the initial portion of the pseudo aneurysm wall turns back and can be seen behind the ruptured wall.
An extensive calcified left ventricular aneurysm ibrahim araç
This document summarizes a case study of a surgical procedure to repair a calcified left ventricular aneurysm. A 66-year-old man presented with shortness of breath and a history of cardiac arrest. Tests revealed a dilated cardiomyopathy and large aneurysm in the left ventricle. The patient underwent open-heart surgery using cardiopulmonary bypass to perform an endarterectomy on a blocked coronary artery and repair the aneurysm using an internal circular patch technique known as the Dor procedure. The surgery was successful and the patient was discharged after a week without complications. Surgical repair of large or symptomatic aneurysms can help restore normal heart geometry and reduce strain on the left ventricle.
This study evaluated outcomes of 26 patients who underwent surgical repair of post-myocardial infarction ventricular septal defect (VSD) at Nizams Institute of Medical Sciences between 1997-2012. 20 patients underwent VSD repair with concomitant coronary artery bypass grafting, while 6 had VSD closure alone. The mean time between MI and VSD appearance was 7.2 days, and between VSD appearance and surgery was 27.2 days. Overall in-hospital mortality was 30.9% and 30-day mortality was 33%. Patients who underwent emergency surgery within 3 days of MI had 100% mortality, while those operated on after 3 weeks had 100% survival. Concomitant CABG during VSD repair was associated with lower
This document discusses an echocardiogram of a patient with a quadricuspid pulmonary valve. The echocardiogram shows opening of the pulmonary valve during atrial contraction, indicating low pulmonary artery pressure and ruling out pulmonary stenosis. Pulmonary flow Doppler measurements initially showed a gradient of 29 mmHg but were underestimated based on M-mode findings and misalignment of the pulmonary jet. Repeating the measurement from a subcostal view yielded a gradient of 41 mmHg, still considered an underestimate.
pre and post transplant echo , contrast echo Leonardo Vinci
This document discusses the use of contrast echocardiography for pre- and post-operative evaluation of heart transplant patients. It outlines how echocardiography is used to evaluate donor hearts prior to transplantation, assess for complications immediately after transplantation, and monitor cardiac structure and function long-term. Contrast echocardiography helps improve endocardial border visualization and allows for more accurate assessment of parameters like ventricular volumes and ejection fraction both before and after transplantation. The document also discusses the role of echocardiography in diagnosing issues like rejection and transplant coronary artery disease.
The document discusses updates to guidelines for defining and diagnosing pulmonary hypertension from the 5th World Symposium on Pulmonary Hypertension held in 2013. Key points include: maintaining the general definition of PH as a mPAP over 25 mm Hg, collecting more data on borderline PH cases with mPAP between 21-24 mm Hg, and not reintroducing exercise-induced PH criteria due to a lack of suitable definition. Recommendations are also provided on measuring and interpreting pulmonary vascular resistance and pulmonary artery wedge pressure during right heart catheterization.
The SIGNIFY trial investigated the effects of ivabradine in 19,102 patients with stable coronary artery disease without heart failure. It found that ivabradine reduced heart rate but did not improve cardiovascular outcomes and increased adverse events compared to placebo. However, ivabradine was found to improve angina symptoms in patients who had angina at baseline. The results contrast with previous studies and suggest that reducing heart rate may not benefit stable coronary artery disease as it does heart failure.
This document summarizes the BRIDGE study published in NEJM in 2015, which compared bridging anticoagulation versus no bridging in atrial fibrillation patients undergoing elective surgery requiring interruption of warfarin therapy. The study found discontinuing warfarin without bridging anticoagulation was noninferior to bridging in preventing arterial thromboembolism and resulted in less major and minor bleeding compared to bridging. Bridging anticoagulation tripled the risk of major bleeding but did not reduce thromboembolic risks. The findings suggest perioperative thromboembolism risk in AF may be overstated and not mitigated by bridging, which increases bleeding risks.
This document discusses methods for evaluating the function of prosthetic heart valves. It begins by introducing different types of prosthetic valves and the importance of assessing valve function. The key methods discussed include clinical examination, chest x-ray, 2D echocardiography, Doppler echocardiography, TEE, 3D echo, cinefluoroscopy, CT scanning, and cardiac catheterization. Echocardiography poses technical challenges due to shadowing from prosthetic valves but allows assessment of hemodynamics and detection of dysfunction.
Ventricular assist devices (VADs) are mechanical pumps that help the failing heart pump blood. There are two main types - pulsatile VADs that pump blood in pulses and continuous flow VADs that pump blood continuously. VADs are used as a bridge to heart transplant, to help the heart recover, or as destination therapy for those not eligible for transplant. They are implanted using cardiopulmonary bypass to connect the inflow cannula in the left ventricle to the outflow cannula in the aorta. VADs improve heart function and quality of life for patients with heart failure.
This document discusses heart failure with normal ejection fraction (HFNEF). It defines HFNEF and explains that nearly half of heart failure patients have normal ejection fraction. The pathophysiology of HFNEF involves diastolic dysfunction, systolic dysfunction, impaired ventricular vascular coupling, and other factors. The document examines mechanisms of diastolic dysfunction like relaxation abnormalities, stiffness, and the role of calcium and titin. It discusses the diagnosis and evaluation of HFNEF.
Intracoronary optical coherence tomography (OCT) provides high resolution imaging of the coronary arteries to identify vulnerable plaques. OCT uses light instead of sound waves like intravascular ultrasound to achieve 10x higher resolution. This allows visualization of the detailed layers and composition of artery walls and plaques. OCT is used to diagnose blockages, guide interventions like stenting, and identify high-risk plaques to prevent heart attacks. Future developments include automated plaque characterization, combined OCT/ultrasound catheters, and molecular imaging with near infrared fluorescence to identify inflammation.
Ventricular septal defect after myocardial infarctionRamachandra Barik
This document discusses ventricular septal defects (VSDs) that occur after a myocardial infarction. It provides several key points:
1. Surgical repair is the gold standard treatment for post-infarction VSD, but patients are at high risk for complications and mortality rates remain poor.
2. Transcatheter device closure of VSDs is an emerging alternative to surgery, with studies showing high rates of technical success but also risks of major complications and death within 30 days.
3. Factors associated with increased mortality from both surgical repair and device closure include older age, cardiogenic shock, renal dysfunction, and larger defect size. Overall, post-infarction VSD continues to carry
This document summarizes a clinical trial evaluating the safety and effectiveness of catheter-based renal denervation for treating uncontrolled hypertension. The trial was a prospective, randomized, single-blind study comparing renal denervation to a sham control procedure in over 500 patients. The trial met its primary safety endpoint but did not meet its primary efficacy endpoint of a reduction in systolic blood pressure of at least 5 mmHg. In response, the manufacturer suspended enrollment in other renal denervation hypertension trials pending further review, but will continue post-market surveillance and studies of non-hypertension indications based on the procedure's demonstrated safety profile.
This document provides an overview of cardiac resynchronization therapy (CRT), including indications, assessment of dyssynchrony, rationale/mechanism, trials, procedures, and programming. It discusses the types and assessment of cardiac dyssynchrony using ECG, echocardiography, MRI, and nuclear imaging. Key trials on CRT are summarized, showing benefits for heart failure patients with reduced ejection fraction and wide QRS duration or echocardiographic evidence of dyssynchrony even in narrow QRS.
This document provides instructions for a transesophageal echocardiogram (TEE) orientation by listing the ultrasound views and their abbreviations to be obtained, including transgastric basal and mid short-axis views, 2 chamber view, and views of the ascending aorta, vena cava, pulmonary veins and right ventricle inflow. Measurements are provided in parentheses for some views.
This document discusses coronary artery disease and the abnormalities seen on echocardiography. It covers the pathophysiology of coronary syndromes and describes techniques for detecting wall motion abnormalities. It then details various complications that can occur with acute myocardial infarction such as pericardial effusions, infarct expansion, ventricular thrombi, and mitral regurgitation. Chronic complications of coronary artery disease discussed include left ventricular aneurysms, mural thrombi, and remodeling.
This document provides information on transposition of the great arteries (TGA), including its definition, theories of development, morphology, clinical features, diagnosis, and management. Some key points:
- TGA is a congenital heart defect where the aorta arises from the right ventricle and the pulmonary artery arises from the left ventricle, rather than their normal positions.
- There are several theories for its development during embryogenesis. Its morphology involves abnormalities in the ventricles, arteries, valves, and other structures compared to normal.
- Presentation depends on mixing between circulations. Poor mixing in infants with intact septum leads to severe cyanosis. Better mixing with a VSD or P
This document summarizes coarctation of the aorta, including types, presentations, diagnostic evaluations, and interventions. Coarctation can be localized, involve tubular hypoplasia, or be an interruption. It often presents with hypertension and reduced pulses. Diagnosis involves evaluating gradients on angiography or echocardiogram. Treatment is usually catheter-based balloon angioplasty or stenting, though surgery was used historically. Complications include aneurysms, dissection, or recoarctation so follow-up is important.
Radical nephrectomy for locally advanced renal cell carcinoma (RCC) involves complete removal of the kidney, surrounding tissue, and regional lymph nodes. It may also include adrenalectomy. The surgical procedure is complex due to the need for careful dissection near major blood vessels and organs. While lymph node dissection and adjuvant therapy were once used widely, current evidence does not support a survival benefit. For RCC with inferior vena cava involvement, preoperative imaging and planning is important. Recent trials found that adjuvant pembrolizumab improved disease-free survival compared to placebo after surgery for locally advanced RCC.
This document discusses post-myocardial infarction ventricular septal rupture (VSR). It notes that VSR incidence has decreased with improved reperfusion therapies. Surgical repair is the definitive treatment but is high risk, while percutaneous closure and mechanical support have improved outcomes. The timing and presentation of VSR depends on its pathophysiology, which can include acute or delayed rupture. Diagnosis is via echocardiography. Management involves surgical closure if stable, while unstable patients may be supported with devices or surgery delayed. Percutaneous closure is an option for inoperable cases.
This document discusses sinus of Valsalva aneurysm (SVA), which is a rare cardiac anomaly where the wall of the sinus of Valsalva is weakened, forming a bulge or outpouching. SVAs can be congenital or acquired and most commonly originate from the right coronary sinus. Unruptured SVAs may be asymptomatic but can cause complications like heart failure. Ruptured SVAs often present with sudden chest pain and heart murmur, and can lead to cardiac tamponade, arrhythmias, or sudden death if ruptured into the pericardium. Echocardiography, CT, MRI and angiography can help in diagnosis. Surgery is the standard treatment but device closure is
This case report describes a 69-year-old male patient who presented with an isolated right common iliac artery aneurysm measuring 8 cm in diameter. During pre-operative workup for planned open surgical repair, the patient's condition deteriorated and imaging showed rupture of the aneurysm. The patient underwent an emergency retroperitoneal surgical procedure to ligate the right iliac artery, perform an extra-anatomic femorofemoral bypass, and repair the ruptured aneurysm. Post-operatively, the patient recovered well with all pulses intact. Isolated iliac artery aneurysms are rare but can rupture with high mortality if not repaired. Both open surgical and endovascular techniques are used for treatment.
Venous disorders of the lower limbs, general surgeryshaymadeeb
1) Venous disorders are common, affecting up to 40% of adults. They include chronic venous disease, deep vein thrombosis, and superficial thrombophlebitis.
2) The venous system has deep veins that accompany arteries and superficial veins located more superficially, connected by perforating veins. Chronic venous disease is caused by chronic venous hypertension from valvular problems or thrombosis.
3) Common venous disorders include varicose veins, which are enlarged, tortuous superficial veins caused by valve incompetence, and chronic venous insufficiency, which involves leg swelling, skin changes, and possibly ulcers from long-standing valvular problems.
Mechanical complications Post AMI and the role of CABG.pptxNora Albogami
Mechanical complications such as ventricular septal rupture, left ventricular free wall rupture, and papillary muscle rupture are lethal complications of acute myocardial infarction. While rare, occurring in only a small fraction of AMI cases, they carry extremely high mortality rates even with optimal treatment. Ventricular septal rupture has a mortality rate of 19-54% with surgery and is almost uniformly fatal with medical management alone. Left ventricular free wall rupture presents with sudden cardiac tamponade and is also rapidly fatal without surgery. Surgical repair techniques aim to exclude the injured myocardium with patches, though outcomes remain poor. Early stabilization is crucial to improving survival from these catastrophic AMI complications.
Ventricular septal defects (VSDs) are congenital holes in the wall separating the left and right ventricles of the heart. Henri Roger first described VSDs in 1879. VSDs are classified based on their location, with the main types being membranous, muscular, inlet, and outlet. The size of the defect determines the severity, with smaller defects having little impact and larger defects causing significant left-to-right shunting of blood. Symptoms range from none with small defects to heart failure in infants with large defects. Treatment may involve monitoring for closure, surgery, or device closure depending on the size and impact of the defect.
This document discusses the anatomy and ultrasound evaluation of veins in the upper extremity. It describes the cephalic, basilic, brachial, axillary, subclavian, and internal jugular veins. The technical procedure for venous doppler ultrasound is outlined, including patient positioning, scanning techniques, and diagnostic criteria. Potential pitfalls like rouleaux and limited windows are noted. Chronic changes after deep vein thrombosis like valve changes and collateral veins are also described. Ultrasound is useful for evaluating suspected deep vein thrombosis and mapping veins for dialysis access planning.
The document discusses thoracic aortic aneurysms (TAAs), including:
1. TAAs can be true aneurysms involving all vessel layers, or pseudoaneurysms where the intimal and medial layers are disrupted. Common types are fusiform and saccular.
2. Etiologies include atherosclerosis, cystic medial necrosis from conditions like Marfan syndrome, infections, vasculitides, trauma, and congenital factors.
3. Imaging plays a key role in evaluating TAAs to characterize morphology, size, relationships to other structures, and signs of rupture risk. Management depends on aneurysm location and size.
The interventricular septum separates the left and right ventricles of the heart. A ventricular septal defect (VSD) is an opening in the septum that allows blood to shunt between the ventricles. VSDs can occur anywhere in the septum and range in size from small to large. Larger VSDs often present in infants with symptoms like breathing difficulties. Echocardiography is the primary imaging method used to diagnose VSDs, and larger defects may require surgical closure to prevent complications like heart failure.
Transposition of great arteries with lvoto managementIndia CTVS
Transposition of the great arteries (TGA) with left ventricular outflow tract obstruction (LVOTO) can be managed through various surgical options depending on the severity and type of LVOTO. The Rastelli procedure and Lecompte procedure are two common definitive corrective surgeries that involve tunneling the left ventricle to the aorta while connecting the right ventricle to the pulmonary artery with or without a conduit. The Nikaidoh procedure, or aortic translocation, is an alternative used when anatomy is unsuitable for Rastelli or Lecompte, involving translocating the aortic root posteriorly to relieve LVOTO. Long-term outcomes of these procedures can include reintervention needs but provide
A 50-year-old woman presented with worsening shortness of breath, cough, haemoptysis and weight loss over 3 months. CT scan showed a large superior mediastinal mass encasing blood vessels and the right main bronchus, with lymph node involvement. Biopsy of a neck lymph node confirmed small cell lung cancer. The patient's symptoms worsened and she was admitted as an emergency. Radiation, chemotherapy, surgery and stents are treatments for superior vena cava obstruction, with the approach depending on factors like tumor type, extent of disease, and performance status. Relief of symptoms is often seen within days of starting treatment.
Coarctation of Aorta by Dr Kuntal SuranaKuntal Surana
This document provides information on coarctation of the aorta, including its definition, embryology, types, diagnosis, and surgical management. Coarctation of the aorta is a narrowing of the aorta beyond the level of the innominate artery. It can be caused by abnormal ductal tissue formation or reduced blood flow affecting development in utero. Types include preductal and postductal. Diagnosis involves imaging like echocardiogram, CT, or MRI to identify the narrowing. Surgical techniques to repair coarctation include resection with end-to-end anastomosis, prosthetic patch aortoplasty, and subclavian flap aortoplasty. Untreated coarctation
The document discusses echocardiographic evaluation of the pericardium. It describes the normal anatomy of the pericardium and physiology. Small amounts of pericardial fluid are normal but larger accumulations can indicate a pericardial effusion. Echocardiography is useful for diagnosing and characterizing pericardial effusions, identifying pericardial thickening, and evaluating conditions like cardiac tamponade and constrictive pericarditis. CT and MRI can provide additional information about pericardial abnormalities.
A retired colonel presented to the emergency room with chronic chest pain. Further evaluation revealed he had a massive haemothorax secondary to a ruptured aortic aneurysm. Autopsy showed aortic aneurysms are caused by alterations to the delicate balance in the aortic wall that leads to dilatation. Thoracic aortic aneurysms are generally repaired electively when they reach a diameter of 6 cm or greater to prevent fatal rupture. Treatment options include open surgical repair or endovascular stent graft placement depending on the location and extent of the aneurysm.
This document discusses the anatomy, embryology, and imaging of the superior vena cava (SVC). It begins with an introduction to the SVC's role as the largest central vein in the mediastinum. Imaging plays an important role in identifying congenital variants and pathologies. The document then covers the embryological development of the SVC, its normal anatomy and tributaries, and techniques for imaging it with various modalities like CT, MR, and venography. It discusses congenital variants like persistent left SVC and aneurysms. It also reviews acquired conditions like strictures, thrombus, and various tumors that can affect the SVC.
Similar to Leftventricularaneurysm 130208122724-phpapp02 (20)
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
2. TIMELINE FACTS COMMENTS
1757
1881
1912
1944
1951
1955
1958
LV ANEURYSM by
autopsy
LVA+ CAD
Congenital LVA Rx-
surgical ligation
Fasciae latae plication.
First LV ANGIOGRAM
LVA repair without CPB
Cooley et al successfully
performed a linearrepair
of a LVA using CPB.
John Hunter
Weitland
Beck
Likoff and Bailey
3. DEFINITION-
•A post-infarction lt ventricular aneurysm is a well delineated transmural
fibrous scar, virtually devoid of muscle, in which the characterstic fine
trabecular pattern of the inner surface of the wall has been replaced by
smooth fibrous tissue.
•During systole the involved wall segments are akinetic or dyskinetic.
•Johnson and colleagues defined aneurysm as “a large single area of
infarction (scar) that causes the LV ejection fraction to be profoundly
depressed (to approximately 0.35 or lower).”
•Although realistically the definition of LV aneurysm is less important to the
surgeon than are criteria for and results of surgical excision of LV scars, lack
of uniformity of definition complicates almost all discussions of this entity.
4. Gross Pathology
•The wall of a mature aneurysm is a white fibrous scar, visible externally on
the cut surface as well as endocardially. Characteristically, the aneurysmal
portion of the LV wall is thin, the endocardial surface is smooth and
nontrabeculated, and the area is clearly demarcated.
•In more than half of patients, varying amounts of mural thrombus are
attached to the endocardial surface. The mural thrombus may calcify, as
may the overlying pericardium, which is often densely adherent to
aneurysm’s epicardial surface.
•Such classic LV aneurysms are at one end of the spectrum of
postinfarction LV scars.
•At the other end are diffuse, scattered, and at times sparse punctate scars,
frequently visible at operation in areas of previous MI.
•These scars are usually not transmural, and the LV wall is not thinned or
only minimally so. The endocardium beneath retains its trabeculations, and
the area of scarring is not clearly demarcated from the rest of the wall.
5. Microscopic Pathology
•A mature aneurysm consists almost entirely of hyalinized fibrous tissue.
However, a small number of viable muscle cells are usually present.
•Fibrous tissue of the type present in aneurysms takes at least 1 month to
form, although collagen is present within 10 days of infarction.
Location
•About 85% of LV aneurysms are located anterolaterally near the apex of
the heart. Few are confined to the lateral (obtuse marginal) area, and only
5% to 10% are posterior, near the base of the heart.
•Posterior, or inferior, aneurysms (i.e., those occurring in the diaphragmatic
portion of the LV) are in some ways different from apical and anterolateral
aneurysms. Nearly half of posterior aneurysms are false aneurysms.
•Virtually all lateral aneurysms are false aneurysms. True posterior wall
postinfarction aneurysms are associated with a high prevalence of
postinfarction mitral regurgitation secondary to ischemia or necrosis of the
papillary muscle.
6. CLINICAL FEATURE AND DIAGNOSTIC CRITERIA
•Small and moderate-sized aneurysms are often associated with no specific symptoms,
although the patient may experience angina because of stenoses in other portions of the
coronary arterial tree.
•Patients with large LV aneurysms, however, usually present with dyspnea that often has
persisted from the time of infarction.
• Heart failure requiring medication for control may have appeared by the time of
presentation to the physician.
• Symptoms related to ventricular tachycardia occur in 15% to 30% of patients and may
become intractable to medical treatment and cause death.
•Although about half of aneurysms contain thrombus, thromboembolism occurs in only a
small proportion of patients.
•On physical examination, palpation over the heart often demonstrates a diffuse,
sustained apical systolic thrust and a double impulse.
•On auscultation, usually a third heart sound and often a fourth (atrial) sound are
present. There may be an apical pansystolic murmur if mitral regurgitation is present.
7. Diagnostic modality
Echocardiography
Screening method for detecting LV aneurysm
Useful for assessing MV function
Cardiac MRI
Chest radiography and fluoroscopy
may show an external bulge or
convexity when the aneurysm is large
enough and profiled. Methods of LV
imaging—namely, left
ventriculography, two-dimensional
and transesophageal
echocardiography, radionuclide
cardiac blood pool imaging, computed
tomography (CT), and magnetic
resonance imaging (MRI)—are all
useful diagnostic techniques
8. NATURAL HISTROY
Development of Lt Ventricular aneurysm
•Historically, about 10% to 30% of patients who survived a major MI
developed an LV aneurysm.
•Occurrence of a large transmural infarction is a prerequisite.
• It has been suggested that patients who develop LV aneurysms have few
intercoronary collateral arteries.
•It is postulated that a rich collateral blood supply to an area of MI tends to
increase the number and size of the islands of viable myocardial cells in the
area and decrease the probability that the necrosis is extensive enough to
result in a thin-walled transmural scar.
•This hypothesis is supported by Forman and colleagues
9. Patho-physiologic progression of aneurysm
•It may be due to a gradual increase in the size of the area of akinesia or
dyskinesia and to a consequent gradual reduction in stroke volume and
global ejection fraction.
•The nonaneurysmal portion of the LV wall is subjected to increased systolic
wall stress as ventricular size increases (as described by the Laplace law)
and may ultimately lose its systolic reserve and contribute to LV enlargement
and failure
Lt ventricular function
•An aneurysm changes the curvature and thickness of the LV wall, and
because these are determinants of LV afterload (wall stress), global LV
performance is altered.
•Also, a large LV aneurysm leads to global cardiac remodeling with
generalized dilatation.
•Variations in intrinsic properties of scar, muscle, and border-zone tissue can
affect both systolic and diastolic function.
•Finally, paradoxical movement in the aneurysmal portion of the wall reduces
efficiency of the ventricle because systolic work is wasted on expansion of
the aneurysm.
10. RV function
This may result from akinesis or dyskinesis of the ventricular septum, impaired RV wall
motion near the apex, increased pulmonary artery pressure, occlusive disease of the
right coronary artery, and increased volume of the LV within the pericardial cavity
Survival
•Patients with an LV akinetic area (not all of which are true aneurysms) are reported to
have a 5-year survival without operation of 69%, perhaps only a little less than that
dictated by their coexisting coronary artery disease.
• Patients with a dyskinetic area of LV wall (many of which are probably aneurysms)
have a 54% 5-year survival, which is reduced to 36% when myocardial function in the
remainder of the ventricle is reduced.Size of the aneurysm is a risk factor for premature
death in surgically untreated patients.
•In patients with small aneurysms (usually without symptoms of heart failure), the
probability of surviving is dictated primarily by severity and extent of the coronary arterial
stenoses and is greater in asymptomatic than in symptomatic patients.
•Prognosis is adversely affected bydyskinesia rather than akinesia in the aneurysm; the
former is usually associated with a low global LV ejection fraction
11. Factors contributing to LV aneurysm
formation
Preserved contractility of surrounding myocardium
Transmural infarction
Lack of collateral circulation
Lack of reperfusion
Elevated wall stress
Hypertension
Ventricular dilatation
Wall thinning
12. Natural course
Recent 5YRS for medically managed LV
dyskinesia : 47~70%
Cause of death
Arrhythmia 44% : Heart failure 33%
Recurrent MI 11% : Non cardiac cause 22%
Factors influencing survival of LV dyskinesia
Age : HF score : Coronary disease severity
Angina duration : Prior infarction : MR
Function of residual ventricle
13. LV remodeling involves apoptosis of normally
perfused peri-infarct tissue
Pathologic condition of postinfarction LV remodeling cause changes
in cellular and biochemical levels
Increased appearance of vacuolated cells in periinfarct zone
indicating apoptotic changes
Upregulation of caspase-3 activity
- key mediator of apoptosis in mammalian cells
15. Patch closure – Endoaneurysmorraphy
by Cooley
Endoventricular circular patch repair-
Dor
16. Technique for repair of anterior left ventricular aneurysm by
linear closure.A, After the aorta is clamped and cardioplegic
solution has been infused, an incision is made in the thinnest
portion of the aneurysm parallel to the interventricular groove. If
pericardial adhesions are dense, the aneurysm can be left
attached to the pericardium. The scar is excised (inset). B, After
all the scar has been excised, traction sutures are placed at
each end of the anticipated line of closure. The defect is closed
with No. 1 or 2 double-armed silk or polyester sutures placed
horizontally and immediately adjacent to one another. These
sutures are placed deep into the ventricular septum to exclude
as much septal scar as possible (inset). C, Suture line is
reinforced with two continuous No. 0 or 1 polypropylene sutures
positioned at each end of the incision, placed in scar tissue
superficially to the mattress sutures, and tied to each other.
17. Technique for repair of anterior left
ventricular aneurysm by patch
closure.A, After the aorta is
clamped and cardioplegic solution
has been infused, an incision is
made in the thinnest portion of the
aneurysm parallel to the
interventricular groove (inset). B, A
purse-string suture of No. 2-0
polypropylene is placed at the line
of demarcation between scar and
contractile myocardium on the
septum and free wall (inset).
Longitudinal and transverse
dimensions of the resulting defect
are measured.
18. Technique for repair of anterior left
ventricular aneurysm by patch closure.
C, A patch of gelatin- or collagen-
impregnated polyester or of polyester
backed with pericardium (inset) is
fashioned with slightly larger
dimensions (0.5 cm) and is sutured
into place, incorporating the purse-
string suture, with a continuous No. 3-
0 polypropylene suture. D,Remnant of
the aneurysmal wall is trimmed and
sutured securely over the patch with a
continuous No. 2-0 polypropylene
suture (inset). Key: LV, Left
ventricle; RV, right ventricle.
19. Replacement of mitral valve through
left ventricle (LV). A, An incision is
made in the thinnest portion of the
aneurysm parallel to the interventricular
groove, and the mitral valve is
examined. Chordae tendineae are
divided at the tips of the papillary
muscles. B, Mitral valve leaflets are
excised. A small rim of anterior leaflet
is left adjacent to aortic valve
cusps. C, Valve holder apparatus is
removed from mechanical valve or
bioprosthesis, and valve is inverted and
suspended by two hemostats.
Interrupted, pledgeted mattress sutures
of No. 2-0 polyester are placed through
the mitral anulus, with pledgets on atrial
side of anulus. These sutures are then
placed through the sewing ring of the
prosthesis on the underside of the
flanged portion. D, The valve is
lowered into the anulus and the sutures
tied.
24. Dor’s procedure
In the endoventricular circular patch plasty by Dor, the
procedure is carried out under cardioplegia.
The left ventriculotomy is performed in the akinetic or
dyskinetic zone (transaneurysmal ventriculotomy), the
thrombus is removed .
An endoventricular circular suture (Fontan maneuver) is placed
1 cm distal to the border of healthy muscle in order to prevent
its inclusion and allows recreation of the normal shape of LV
using continuous 2-0 monofilament polypropylene suture.
25. Dor’s procedure
Following this, a balloonis placed in LV cavity and inflated to the
theoretical diastolic volume of 50—70 ml/m2, and the circular suture
is tightened and tied up.
This maneuver makes the definition of the circular patch size easier,
which can consist of autologous (endocardium or pericardium) or
synthetic tissue.
The patch size is trimmed to match the circular suture circumference
after deflation of the balloon.
The patch is fixed by a continuous 2-0 suture inside the LV cavity on
the border labeled by the circular suture.
27. Outcomes and prognosis
Low early mortality
2-13%
Acceptable 5 and 10 year mortality
5 year survival 58-80%
10 year survival 30% ( better than medical Tx)
Most patients experience increased LV performance
LVEF Pulm pressure LV volume MV O↑ ↓ ↓ 2demand ↓Exercise
tolerance ↑
Scientific evidence to be collected through the STICH trial
28. INDICATIONS OF OPERATION
•A large LV aneurysm in a symptomatic patient, particularly one with angina
pectoris but also in one with heart failure, is an indication for operation.
Appropriate CABG is indicated at the time of aneurysmectomy.
•Currently, the patch closure technique for remodeling ventriculoplasty is
the most widely used for repair of anterolateral aneurysms or areas of
akinesis. In view of the high risk of operation in patients with advanced
chronic heart failure, operation may not be indicated when the known risk
factors are highly unfavorable to survival.
•When the LV aneurysm is small or moderate in size, its presence is not an
indication for operation per se. Patients in such situations are advised
about operation based on their coronary artery disease and LV function
rather than on their aneurysm
29. SPECIAL SITUATIONS
Intractable VT
•Although intractable ventricular tachyarrhythmias occur in patients with ischemic heart
disease in the absence of areas of LV scarring, they are more common in patients with
LV aneurysms or extensive fibrosis.
•However, only a small proportion with LV aneurysms develop intractable ventricular
tachycardia.
•Most patients in whom such an arrhythmia develops have poor global LV function, and
it has been suggested that ventricular tachyarrhythmias are particularly likely to occur
when the ventricular septum has been involved in the infarction.
False left Ventricular Aneurysm
• A false aneurysm may develop after acute rupture of an infarcted area of LV. Such
ruptures are usually fatal, but when the pericardium is sufficiently adherent to the
epicardium, rupture may result only in a localized hemopericardium.
•Persistent communication of the hemopericardium with the LV cavity results in gradual
expansion of the hemo-pericardium into a false aneurysm whose wall is composed of
pericardium and adhesions and occasionally of myocardium, and whose mouth is
usually narrow.
•These aneurysms have a strong tendency to rupture, in contrast to true aneurysms.
•Differentiation between true and false aneurysms can be difficult because the imaging
characteristics of the two entities are often similar.
•However, Doppler color flow imaging and transesophageal echocardiography are
useful techniques for demonstrating the presence of a false aneurysm.
30. Postinfarction Left Ventricular Free Wall Rupture
•Acute rupture of the free wall of the LV is an infrequent but serious complication of
acute MI, occurring in 2% to 4% of patients.
•Among 1048 patients with acute infarction and cardiogenic shock evaluated in the
SHOCK (SHould we emergently revascularize Occluded Coronaries in cardiogenic
shocK?) trial and registry, free wall rupture or tamponade was present in 28 (2.7%).
•It is the second most common cause of death following acute infarction (behind acute
cardiac failure), accounting for up to 20% of early deaths.
•Rupture generally occurs between 1 and 7 days after the infarction.
Congenital Left Ventricular Aneurysm
•Congenital LV aneurysm is a rare malformation characterized by thinning of the
myocardium, with layers of myocardial cells intermingled with various amounts of fibrous
tissue.
• It is usually located at the apex of the LV and has a broad neck.This entity differs from
a congenital diverticulum of the LV, which is a noncontractile bulging of the LV into the
epigastrium.
•The latter is characterized by an elongated shape and a narrow connection with the LV
cavity. It is also associated with midline thoracic and anterior abdominal defects.
Traumatic Left Ventricular Aneurysm
Rarely, violent nonpenetrating chest trauma produces such a severe contusion of the
heart that a localized aneurysm forms.Vascular injury and intramyocardial dissection
resulting from blunt trauma may also lead to aneurysm formation
31. The STICH trial
(Surgical Treatment for Ischemic Heart Failure)
Target registry 2800 patients with 90 participating centers
Objectives to seek best treatment for
coronary disease and heart failure
(Inclusive of SVR)
Groups
Medical therapy alone
Medical therapy & CABG
Medical therapy & CABG and SVR